Article Versions Notes

Tajima G, Aisaki J, Hara K, Tsumura M, Kagawa R, Sakura F, Sasai H, Yuasa M, Shigematsu Y, Okada S. Using the C14:1/Medium-Chain Acylcarnitine Ratio Instead of C14:1 to Reduce False-Positive Results for Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency in Newborn Screening in Japan. International Journal of Neonatal Screening. 2024; 10(1):15. https://doi.org/10.3390/ijns10010015

Tajima, Go, Junko Aisaki, Keiichi Hara, Miyuki Tsumura, Reiko Kagawa, Fumiaki Sakura, Hideo Sasai, Miori Yuasa, Yosuke Shigematsu, and Satoshi Okada. 2024. "Using the C14:1/Medium-Chain Acylcarnitine Ratio Instead of C14:1 to Reduce False-Positive Results for Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency in Newborn Screening in Japan" International Journal of Neonatal Screening 10, no. 1: 15. https://doi.org/10.3390/ijns10010015

Tajima, G., Aisaki, J., Hara, K., Tsumura, M., Kagawa, R., Sakura, F., Sasai, H., Yuasa, M., Shigematsu, Y., & Okada, S. (2024). Using the C14:1/Medium-Chain Acylcarnitine Ratio Instead of C14:1 to Reduce False-Positive Results for Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency in Newborn Screening in Japan. International Journal of Neonatal Screening, 10(1), 15. https://doi.org/10.3390/ijns10010015